Organ-on-a-Chip (OOC)

“Organ-on-a-chip” technology is a scientific breakthrough that makes it possible to create a living model that simulates the activity of a human organ, on a tiny chip. The goal of this development is to build an experimental system that reproduces, with a high degree of accuracy, the physiological conditions found in the human body, thereby enabling researchers to study diseases, test drugs, and understand biological processes in a deeper and more efficient manner.

The technology combines tissue engineering with microfluidic systems, miniature systems that make it possible to direct and control fluids with microscopic precision. This combination provides cells with a three-dimensional environment that mimics their natural living conditions within the body and makes it possible to reproduce the spatial organization of the tissue, intercellular communication, and the way cells respond to their physical surroundings.

The chip itself is generally made from a transparent and flexible polymer material such as PDMS, within which microscopic channels are constructed to allow the flow of essential nutrient fluids. Inside these channels, or on permeable membranes separating them, human cells corresponding to the organ being studied, such as lung cells or blood vessel cells, are grown. The continuous flow of fluids not only supplies the cells with nutrients but also creates shear stress, a mechanical force generated by continuous flow that directly affects cellular and tissue function within the body.

One of the main advantages of these systems is the ability to exercise precise control over the cells’ working environment. Researchers can determine and modify factors such as oxygen concentration, acidity level, and nutrient composition, and can even apply mechanical forces such as cyclic stretching to simulate dynamic processes like breathing or heartbeats. This complete level of control creates a highly reliable experimental model, and as a result the technology is now used as an essential tool in disease research, drug toxicity testing, and the evaluation of clinical efficacy.

“Organ-on-a-chip” technology provides an important solution in the field of drug development and is considered one of the most promising approaches in biomedical research. It offers significant potential for accelerating drug development, supporting personalized medicine, and improving the ability to predict in advance the effects of innovative treatments on humans.

Frequently Asked Questions

1. What is “organ-on-a-chip” technology?

It is a miniature laboratory system that simulates the physiological activity of a human organ, such as a lung, liver, or kidney, on a chip. The system combines living human cells with tiny channels through which fluids flow under controlled conditions, thereby recreating the organ’s natural environment within the body and enabling experiments and research that are as close as possible to real human physiology.

2. Why is “organ-on-a-chip” technology sometimes considered more reliable than animal testing?

Animal testing provides valuable information, but because of significant biological and genetic differences among species, it does not always accurately predict how a particular drug or substance will affect humans. “Organ-on-a-chip” systems, by contrast, are based from the outset on human cells and operate in an environment that simulates the unique conditions of the human body, making it possible to obtain results that are more medically relevant and reliable.

3. What physical forces act within “organ-on-a-chip” systems?

In these systems, cells are exposed to physical and mechanical forces that simulate the body’s natural dynamics, such as fluid flow, changing pressure, stretching, and contraction. These mechanical stimuli are critical because they directly affect the cells’ structure, function, and behavior. Without these forces, many cells in the laboratory do not behave as they would inside a living body.

4. What is a “body-on-a-chip,” and how is it related to “organ-on-a-chip” technology?

A “body-on-a-chip” is a more advanced stage of development in which several organ chips, such as liver, kidney, and heart chips, are connected into a single integrated system. This integration allows researchers to examine the interactions and mutual effects among different organs, for example how a drug that is metabolized in the liver subsequently affects kidney function, thereby providing a comprehensive picture of the whole body’s response.

5. How are induced pluripotent stem cells (iPSCs) integrated into “organ-on-a-chip” technology?

Induced pluripotent stem cells are mature cells (for example from blood or skin) that have undergone laboratory reprogramming so they can be differentiated into any desired cell type in the body. Their integration into “organ-on-a-chip” technology makes it possible to create a chip based on the cells of a specific patient, evaluate that patient’s unique response to treatment in advance, and thereby serve as a key tool in the field of personalized medicine.

6. Have health authorities already recognized “organ-on-a-chip” technology?

Yes. In recent years, significant progress has been made, and the world’s leading regulatory authorities have begun formally recognizing the potential of advanced non-animal-based models, including “organ-on-a-chip” systems. The technology is now regarded as a valid and highly valuable scientific tool in drug development processes and safety assessment.

7. What are the current limitations of “organ-on-a-chip” technology?

Despite its clear advantages, the technology is still unable to fully reproduce the complete complexity of a living organism. The main current challenges include integrating comprehensive systems such as the immune system or the hormonal system within a single chip. In addition, some of the polymer materials used to manufacture the chips may absorb drug molecules, thereby interfering with measurements, limitations that are currently the subject of ongoing development and efforts to resolve them.

8. How does “organ-on-a-chip” technology assist in the study of infectious diseases?

The technology makes it possible to study, within a controlled and safe environment, how viruses or bacteria attack specific human tissues. For example, the use of a “lung-on-a-chip” allows researchers to precisely track how a respiratory infection develops within lung cells and affects the adjacent blood vessels, thereby helping to understand disease mechanisms and evaluate the effectiveness of relevant treatments in the fields of public health and infectious diseases.